An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of different resourcing scenarios, the group’s head turned to BTG. We delivered an independent pharmacovigilance organization specialist and former engagement lead in Accenture’s life science practice. She worked with internal executives to evaluate the most efficient model, then develop detailed organization-wide communication and implementation plans.
Improve patient outcomes and brand performance.
Problem Solvers on Demand
- Blog
- Industries
-
Capabilities
- Capabilities
- COVID-19
- Strategy
- Operations
- Project Management
- Interim Executives
- Digital Transformation
- Supply Chain
- Data Science
- Marketing & Sales
- Finance
- Human Resources
- Transformations
- Mergers & Acquisitions
- Market Access & Value
- Clinical Solutions
- Life Science Strategy and M&A
- Life Science Supply Chain and Manufacturing
- Commercial Excellence
- Big Ideas
- Resource Types
